Jingmei Su

524 total citations
11 papers, 402 citations indexed

About

Jingmei Su is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jingmei Su has authored 11 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Jingmei Su's work include Angiogenesis and VEGF in Cancer (3 papers), Cancer Research and Treatments (2 papers) and Immunotherapy and Immune Responses (2 papers). Jingmei Su is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cancer Research and Treatments (2 papers) and Immunotherapy and Immune Responses (2 papers). Jingmei Su collaborates with scholars based in China and United States. Jingmei Su's co-authors include Jeanine Kleeman, Barbara Garmy‐Susini, Hui Jin, Judith A. Varner, Jiyan Liu, Longhao Li, Xingchen Peng, Benxu Tan, Dong Hang and Jun Ge and has published in prestigious journals such as Cancer, Cancer Research and Journal of Molecular Medicine.

In The Last Decade

Jingmei Su

11 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingmei Su China 8 239 187 83 67 56 11 402
Mahesh V. Padval United States 8 227 0.9× 190 1.0× 65 0.8× 39 0.6× 108 1.9× 22 482
Mitsuhiko Ogaki Japan 8 221 0.9× 123 0.7× 131 1.6× 39 0.6× 27 0.5× 9 370
Zhuonan Zhuang China 9 213 0.9× 150 0.8× 147 1.8× 97 1.4× 41 0.7× 16 410
Langzhu Tan United States 8 252 1.1× 77 0.4× 53 0.6× 45 0.7× 23 0.4× 9 362
Stacey Mont United States 10 142 0.6× 81 0.4× 70 0.8× 49 0.7× 68 1.2× 12 345
Marja Hilska Finland 9 166 0.7× 299 1.6× 203 2.4× 37 0.6× 38 0.7× 11 476
Taro Yumioka Japan 9 181 0.8× 130 0.7× 64 0.8× 163 2.4× 50 0.9× 9 381
Yoshihiro Tanimori Japan 9 184 0.8× 135 0.7× 136 1.6× 35 0.5× 19 0.3× 9 379
Hyeong‐Reh Choi Kim United States 5 230 1.0× 129 0.7× 185 2.2× 22 0.3× 81 1.4× 7 433
Un-Jung Yun South Korea 6 289 1.2× 202 1.1× 170 2.0× 42 0.6× 29 0.5× 10 511

Countries citing papers authored by Jingmei Su

Since Specialization
Citations

This map shows the geographic impact of Jingmei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmei Su more than expected).

Fields of papers citing papers by Jingmei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmei Su. The network helps show where Jingmei Su may publish in the future.

Co-authorship network of co-authors of Jingmei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmei Su. A scholar is included among the top collaborators of Jingmei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmei Su. Jingmei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ge, Jun, Hongfeng Gou, Ye Chen, et al.. (2013). Clinical Characteristics of Patients With Solitary Pulmonary Mass After Radical Treatment for Primary Cancers: Pulmonary Metastasis or Second Primary Lung Cancer?. Cancer Investigation. 31(6). 397–403. 8 indexed citations
2.
Tan, Benxu, Ye Chen, Li V. Yang, et al.. (2011). Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. Journal of Molecular Medicine. 89(6). 595–602. 66 indexed citations
3.
Tan, Benxu, W. Yao, Jun Ge, et al.. (2011). Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer. 117(22). 5103–5111. 144 indexed citations
4.
Cheng, Ke, Yang Wu, Xingchen Peng, et al.. (2011). Interleukin-15 enhances T-cell responses by stimulation with dendritic cells. Clinical & Translational Oncology. 13(4). 275–280. 3 indexed citations
5.
Gao, Feng, Ke Cheng, Feng Zhao, et al.. (2011). Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China.. PubMed. 12(11). 2825–8. 13 indexed citations
6.
Tan, Guang‐Hong, Jingmei Su, Feng‐Ying Huang, et al.. (2007). A Recombinant DNA Plasmid Encoding the Human Interleukin-5 Breaks Immunological Tolerance and Inhibits Airway Inflammation in a Murine Model of Asthma. International Archives of Allergy and Immunology. 145(4). 313–323. 15 indexed citations
7.
Jin, Hui, Jingmei Su, Barbara Garmy‐Susini, Jeanine Kleeman, & Judith A. Varner. (2006). Integrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors. Cancer Research. 66(4). 2146–2152. 109 indexed citations
8.
Hu, Bing, Yuquan Wei, Ling Tian, et al.. (2005). Active Antitumor Immunity Elicited by Vaccine Based on Recombinant Form of Epidermal Growth Factor Receptor. Journal of Immunotherapy. 28(3). 236–244. 18 indexed citations
9.
Wu, Yang, Li Yang, Bing Hu, et al.. (2005). Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Anti-Cancer Drugs. 16(5). 551–557. 23 indexed citations
10.
Luo, Yan, Ling Tian, Yang Wu, et al.. (2004). [Prokaryotic expression, purification and refolding of extracellular ligand binding domains of chick Tie-2 and its immunogenicity].. PubMed. 35(2). 154–7. 1 indexed citations
11.
Wu, Yang, Yang Li, Jingmei Su, et al.. (2004). [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].. PubMed. 21(6). 557–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026